System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
Authors:
- 1 March 2010
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 12 (3) , 221-231
Abstract
Background: Blood glucose (BG) monitoring systems enable diabetes patients to effectively control and adjust their therapy. BG monitoring systems with a Conformité Européenne (CE) label should meet the standard DIN EN ISO 15197:2003: ≥95% of the BG results shall fall within ±15 mg/dL of the reference method at BG concentrations Methods: We evaluated 27 BG monitoring systems from 18 manufacturers for system accuracy according to DIN EN ISO 15197:2003. Twenty-four systems were compared with the glucose oxidase reaction (YSI 2300 glucose analyzer [YSI Life Sciences, Yellow Springs, OH]) and three systems with the hexokinase reaction (Hitachi 917 [Roche Diagnostics GmbH, Mannheim, Germany]). Duplicate measurements of 100 blood samples with a defined distribution of BG concentrations from 20 mg/dL to 600 mg/dL from ≥100 subjects were included in the evaluation. Results: Sixteen of the 27 BG monitoring systems fulfilled the minimum accuracy requirements of the standard, i.e., ≥95% of their results showed the minimum acceptable accuracy. Overall, the mean percentage of results showing the minimum acceptable accuracy was 95.2 ± 5.2%, ranging from 80.0% to 100.0%. Conclusions: More than 40% of the evaluated BG monitoring systems did not fulfill the minimum accuracy requirements of DIN EN ISO 15197:2003. As inaccurate BG monitoring systems bear the risk of false treatment decisions by the diabetes patient and subsequent possible severe health injury, manufacturers should regularly and effectively check the quality of BG meters and BG test strips.Keywords
This publication has 18 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Economic and Clinical Aspects of Diabetes Regarding Self-Monitoring of Blood GlucoseDiabetes Technology & Therapeutics, 2008
- Self‐monitoring of blood glucose in type‐2 diabetes: what is the evidence?Diabetes/Metabolism Research and Reviews, 2007
- Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetesCurrent Medical Research and Opinion, 2006
- Self-monitoring of glucose in type 2 diabetes mellitus:a Bayesian meta-analysis of direct and indirect comparisonsCurrent Medical Research and Opinion, 2006
- Current evidence regarding the value of self-monitored blood glucose testingThe American Journal of Medicine, 2005
- Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Who Are Not Using InsulinDiabetes Care, 2005
- Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)Current Medical Research and Opinion, 2005
- U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study GroupDiabetes, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993